Radiographic and histological evaluation of bone formation induced by rhBMP-2-incorporated biomimetic calcium phosphate material in clinical alveolar sockets preservation
- PMID: 37843657
- PMCID: PMC10579201
- DOI: 10.1186/s40729-023-00491-1
Radiographic and histological evaluation of bone formation induced by rhBMP-2-incorporated biomimetic calcium phosphate material in clinical alveolar sockets preservation
Abstract
Purpose: We assessed the efficiency of low-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) incorporated biomimetic calcium phosphate on β-tricalcium phosphate (β-TCP) (rhBMP-2/BioCaP/β-TCP) on bone formation in a model of socket preservation using cone beam computed tomography (CBCT) scanning and histological examination.
Methods: Forty patients undergoing minimally invasive single-root tooth extraction for dental implantation were randomized to three groups according to the material used for socket preservation: filling with rhBMP-2/BioCaP/β-TCP, β-TCP, or natural healing (kept unfilled) (controls). The alveolar sockets (including the control group) were covered by two-layer collagen membranes and sutured. Two CBCT scans were taken, one immediately after socket preservation procedure (baseline) and another 6 weeks later. Gray values (GVs) obtained from CBCT were recorded. During insertion of the dental implant, biopsies were taken and analyzed histologically for new bone formation, residual material, and unmineralized bone tissue at the core of the biopsy.
Results: The mean (± standard deviation) changes of GVs of the CBCT scans at the central area of filled materials were as follows: 373.19 ± 157.16 in the rhBMP-2/BioCaP/β-TCP group, 112.26 ± 197.25 in the β-TCP group, and -257 ± 273.51 in the control group. The decrease of GVs in the rhBMP-2/BioCaP/β-TCP group as compared with the β-TCP group was statistically significant (P < 0.001). Differences in new bone formation (P = 0.006) were also found: 21,18% ± 7.62% in the rhBMP-2/BioCaP/β-TCP group, 13.44% ± 6.03% in the β-TCP group, and 9.49% ± 0.08% in controls. The residual material was10.04% ± 4.57% in the rhBMP-2/BioCaP/β-TCP group vs. 20.60% ± 9.54%) in the β-TCP group (P < 0.001). Differences in unmineralized bone tissue (P < 0.001) were also found (68.78% ± 7.67%, 65.96% ± 12.64%, and 90.38% ± 7.5% in the rhBMP-2/BioCaP/β-TC, β-TCP, and control groups, respectively).
Conclusions: This study shows that rhBMP-2/BioCaP/β-TCP is a promising bone substitute with fast degradation and potent pro-osteogenic capacity that can be useful for socket preservation in implant dentistry.
Trial registration: ChiCTR, ChiCTR2000035263. Registered 5 August 2020, https://www.chictr.org.cn/ChiCTR2000035263 .
Keywords: Biomimetic; Biopsy; Bone regeneration; CBCT; Gray values; Histomorphometry; rhBMP-2.
© 2023. Deutsche Gesellschaft für Implantologie im Zahn‐, Mund‐ und Kieferbereich e.V., Japanese Society of Oral Implantology.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
The Clinical Efficacy and Safety of ErhBMP-2/BioCaP/β-TCP as a Novel Bone Substitute Using the Tooth-Extraction-Socket-Healing Model: A Proof-of-Concept Randomized Controlled Trial.J Clin Periodontol. 2025 Feb;52(2):299-309. doi: 10.1111/jcpe.14084. Epub 2024 Oct 31. J Clin Periodontol. 2025. PMID: 39478364 Free PMC article. Clinical Trial.
-
Efficacy and safety of rhBMP/β-TCP in alveolar ridge preservation: a multicenter, randomized, open-label, comparative, investigator-blinded clinical trial.Maxillofac Plast Reconstr Surg. 2021 Dec 20;43(1):42. doi: 10.1186/s40902-021-00328-0. Maxillofac Plast Reconstr Surg. 2021. PMID: 34928477 Free PMC article.
-
BMP2-Functionalized Biomimetic Calcium Phosphate Graft Promotes Alveolar Defect Healing During Orthodontic Tooth Movement in Beagle Dogs.Front Bioeng Biotechnol. 2020 May 29;8:517. doi: 10.3389/fbioe.2020.00517. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32548104 Free PMC article.
-
Evaluation of poly lactic-co-glycolic acid-coated β-tricalcium phosphate for alveolar ridge preservation: A multicenter randomized controlled trial.J Periodontol. 2021 Apr;92(4):524-535. doi: 10.1002/JPER.20-0360. Epub 2020 Oct 12. J Periodontol. 2021. PMID: 32996128 Clinical Trial.
-
Biphasic Calcium Phosphate in the Extraction Socket Preservation: A Systematic Review.J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1007-S1011. doi: 10.4103/jpbs.jpbs_1003_23. Epub 2024 Apr 16. J Pharm Bioallied Sci. 2024. PMID: 38882837 Free PMC article. Review.
Cited by
-
Radiographical Assessment of Injectable Calcium Phosphate Bone Cement (Osteopaste) in Critical Size Bone Defects of Rabbit's Tibia Model.Malays Orthop J. 2025 Jul;19(2):31-39. doi: 10.5704/MOJ.2507.005. Malays Orthop J. 2025. PMID: 40852096 Free PMC article.
-
Local delivery of pamidronate with collagen matrix mitigates buccal bone resorption following immediate implant placement - An experimental in vivo study.J Periodontal Res. 2025 Mar;60(3):255-264. doi: 10.1111/jre.13342. Epub 2024 Aug 26. J Periodontal Res. 2025. PMID: 39187450 Free PMC article.
-
The Clinical Efficacy and Safety of ErhBMP-2/BioCaP/β-TCP as a Novel Bone Substitute Using the Tooth-Extraction-Socket-Healing Model: A Proof-of-Concept Randomized Controlled Trial.J Clin Periodontol. 2025 Feb;52(2):299-309. doi: 10.1111/jcpe.14084. Epub 2024 Oct 31. J Clin Periodontol. 2025. PMID: 39478364 Free PMC article. Clinical Trial.
-
Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 in Socket Preservation: A Randomized Controlled Clinical and Sequential Human Histological Trial (BMP-2 TRIAL).Clin Exp Dent Res. 2025 Jun;11(3):e70134. doi: 10.1002/cre2.70134. Clin Exp Dent Res. 2025. PMID: 40388262 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources